4/A: Anterix Inc. Form 4/A Filing Update
Insider Transaction Amendment
Anterix Inc. files an amended Form 4 to correct a reporting error regarding beneficial ownership of stock options.
Summary
- This filing is an amended Form 4 (Form 4/A) for Christopher Guttman-McCabe, Chief Regulatory & Commercial Officer at Anterix Inc.
- The amendment corrects an inadvertent error in the number of securities reported in column 9 of Table II in a previously filed Form 4 dated June 17, 2026.
- The original filing incorrectly reported the number of securities beneficially owned.
- This Form 4/A is filed solely to correct this specific reporting error; no other changes or amendments are made to the original filing.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, as it is a technical amendment to correct a reporting error without introducing new material information or changes to beneficial ownership.
Positives
- The stock option shares are fully vested, indicating that the reporting person has met the conditions for ownership.
- The correction clarifies the accurate number of securities beneficially owned, ensuring transparency.
Negatives
- An inadvertent reporting error occurred in the original Form 4 filing, requiring an amendment.
Future Outlook
No forward-looking statements or guidance are provided in this filing, as it is solely an amendment to correct a previous reporting error.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insiders of publicly traded companies, ensuring transparency regarding stock transactions and beneficial ownership. Amendments like this are common to correct minor errors and maintain regulatory compliance.
Stakeholder Impact
- Shareholders: Increased transparency and accuracy regarding insider holdings.
Next Steps
- Ensure accurate reporting of beneficial ownership in future filings.
Key Dates
| Date | Description |
|---|---|
| 06/15/2026 | Earliest transaction date. |
| 06/17/2026 | Date of original Form 4 filing. |
| 07/10/2026 | Date of signature for the amended Form 4/A. |
Keywords
Anterix Inc., ATEX, Form 4/A, Beneficial Ownership, Stock Options, SEC Filing, Insider Trading, Securities Exchange Act
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.